ResearcherNorth Sichuan Medical UniversityActive in the last 2 years

Xiao Pang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5135891589. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

Head to head comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a prospective study. Co-author DOI 10.1186/s13550-026-01456-2 ↗
Preclinical Evaluation and First-in-Human Study of [68Ga]Ga-αvβ6-2: A Novel Dimeric Integrin αvβ6-Targeted PET Probe for Pancreatic Cancer Imaging. Co-author DOI 10.1021/acs.molpharmaceut.5c00051 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xinming Zhao · 2 shared papers, 2025–2026 · strength 0.52
- Paper Head to head comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a pr… DOI 10.1186/s13550-026-01456-2 ↗
- Paper Preclinical Evaluation and First-in-Human Study of [68Ga]Ga-αvβ6-2: A Novel Dimeric Integrin αvβ6-Targeted PET Probe fo… DOI 10.1021/acs.molpharmaceut.5c00051 ↗
Ruoxi Yang · 1 shared paper, 2026 · strength 0.26
- Paper Head to head comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT in the diagnosis and staging of pancreatic cancer: a pr… DOI 10.1186/s13550-026-01456-2 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.